KLK3 and prostate carcinoma: The diagnosis of prostate cancer currently relies on a combination of serum prostate-specific antigen (PSA) testing, digital rectal examination (DRE), imaging modalities (e.g., multiparametric MRI), and histopathological confirmation via prostate biopsy [3].